Cosmetic Effects of Topical Acetyl Zingerone

University of California, Davis31 enrolled

Overview

Cosmeceuticals are an emerging market within dermatology and the growth of natural products and derivatives of natural products has accelerated in use within the field. Here the investigators aim to study Synoxyl AZ, the trade name for topical acetyl zingerone (AZ), a novel compound designed based on Zingerone and curcumin. Both curcumin and Zingerone are from the Zingiberacea family of plants (also known as the ginger family). Both have been widely studied and noted to have antibacterial effects and promote skin health effects. Curcumin has been studied widely in recent years due to various microbial effects. AZ is a derivative that is similar to both Zingerone and curcumin and has been noted to have many different activities including anti-inflammatory, antimicrobial, and antioxidant functions. However, there are no studies looking at how it modulates the skin cosmetically or the superficial microbiome. The aim of this study was to compare the cosmetic effects of AZ to a vehicle over an 8-week period.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Wrinkle Appearance Skin Pigment Erythema Side Effect Microbiome Lipidome

Interventions

Acetyl Zingerone Topical CreamOTHER

Topical cream with an active acetyl zingerone component.

Topical creamOTHER

Topical cream without an active acetyl zingerone component and just the carrier cream.

Eligibility

Sex: ALLMin age: 30 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion criteria: * Individuals aged 30-60 * Healthy subjects Exclusion Criteria: * Those that have had topical antibiotics within the past 4 weeks * Those that have had oral antibiotics within past 4 weeks * Those who have used systemic isotretinoin in the last 6 months * Those with a known allergy to members of the ginger family * Current smokers OR 20 pack-year history of smoking OR Have smoked within the past 3 years * Pregnant women * Prisoners * Those who have had any change to their hormonal birth control regimen in the last 4 weeks. * Those with visible signs in the area of application of or on active treatment for cystic acne, eczema, seborrheic dermatitis, papulopustular rosacea at investigator discretion * Those who have had a recent surgical or cosmetic procedure in the last 3 months that can affect facial wrinkles or facial hyperpigmentation, such as botulinum toxin injections, chemical peels, laser based therapies to the face, or face lift surgeries at investigator discretion

Locations (1)

University of California-Davis, Department of Dermatology

Sacramento, California, United States

Outcomes

Primary Outcomes

Change in wrinkle appearance

Change in image based analysis of wrinkle severity from baseline

Time frame: 8 weeks

Change in appearance of skin pigmentation

Change in appearance of image based skin pigmentation from baseline

Time frame: 8 weeks

Secondary Outcomes

Change in skin redness (erythema)

Change in image based skin redness (erythema) and clinical assessment of redness from baseline

Time frame: 4 weeks and 8 weeks

Change in appearance of skin pigmentation

Change in appearance of image based skin pigmentation from baseline

Time frame: 4 weeks

Change in wrinkle appearance

Change in image based analysis of wrinkle severity from baseline

Time frame: 4 weeks

Appearance of side effects such as scaling or irritation

Appearance of side effects such as scaling or irritation from baseline

Time frame: 4 weeks and 8 weeks

Change in superficial microbiome diversity

Change in superficial microbiome diversity from baseline

Time frame: 4 weeks and 8 weeks

Change in superficial lipidome diversity

Change in superficial lipidome diversity from basline

Time frame: 4 weeks and 8 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.